Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Circulation|October 27, 2004
Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout miceNaoki Nozaki, Tetsuro Shishido, Yasuchika Takeishi, et al.
Animals : an Open Access Journal From MDPI|December 9, 2023
Effects of Rumen Fermentation Characteristics on Stress-Related Hormones and Behavior in SheepQianrige, Sanggun Roh, Da-Hye Kim, et al.
Animal Bioscience|February 9, 2021
The effect of daily calf stroking frequency during the postnatal period on the establishment of the human-calf relationshipSatoko Wada, Michiru Fukasawa, Takashi Chiba, et al.
Journal of Cardiac Failure|November 9, 2010
Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failureOlga Bilim, Yasuchika Takeishi, Tatsuro Kitahara, et al.
Journal of Cardiovascular Pharmacology|September 15, 2005
Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injuryHiroki Takahashi, Yasuchika Takeishi, Takanori Arimoto, et al.
Plos One|January 7, 2014
Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunctionMakiko Miyata, Satoshi Suzuki, Tomofumi Misaka, et al.
Heart and Vessels|June 3, 2016
Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapyYoichiro Otaki, Tetsu Watanabe, Hiroki Takahashi, et al.
Circulation Reports|March 11, 2021
Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes MellitusTaro Narumi, Tetsu Watanabe, Shigehiko Kato, et al.
BBA Clinical|December 18, 2015
Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery diseaseYoichiro Otaki, Hiroki Takahashi, Tetsu Watanabe, et al.
International Journal of Cardiology|July 9, 2016
Renal tubular damage is associated with poor clinical outcome in patients with peripheral artery disease who underwent endovascular therapyYoichiro Otaki, Tetsu Watanabe, Hiroki Takahashi, et al.
Pageof 14